Written for clinical oncologists

Addresses the need to improve awareness of newer therapies, increase use of NGS testing, and better manage adverse events through clinician education

Includes discussion of recent FDA approvals, clinical trial results, and updates presented at the 2025 ASCO Genitourinary Cancers Symposium